Trexquant Investment LP Sells 25,581 Shares of The Clorox Company $CLX

Key Points

• Trexquant Investment LP reduced its stake in The Clorox Company by 51.6%, now holding 24,012 shares worth approximately $3.54 million.
• Clorox reported earnings of $2.87 per share for the last quarter, exceeding analysts' expectations and showing a revenue increase of 4.5% year-over-year.
• The company announced a quarterly dividend increase to $1.24 per share, yielding 4.1%, marking a payout ratio of 76.07%.

Trexquant Investment LP trimmed its stake in The Clorox Company (NYSE:CLX - Free Report) by 51.6% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 24,012 shares of the company's stock after selling 25,581 shares during the period. Trexquant Investment LP's holdings in Clorox were worth $3,536,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently modified their holdings of the stock. Mercer Global Advisors Inc. ADV boosted its position in Clorox by 1.4% during the 4th quarter. Mercer Global Advisors Inc. ADV now owns 14,206 shares of the company's stock valued at $2,307,000 after acquiring an additional 201 shares in the last quarter. Aptus Capital Advisors LLC bought a new stake in Clorox during the 4th quarter valued at approximately $801,000. Algert Global LLC bought a new stake in Clorox during the 4th quarter valued at approximately $4,689,000. Ameriprise Financial Inc. boosted its position in Clorox by 14.8% during the 4th quarter. Ameriprise Financial Inc. now owns 245,686 shares of the company's stock valued at $39,902,000 after acquiring an additional 31,624 shares in the last quarter. Finally, BNP Paribas Financial Markets boosted its position in Clorox by 20.4% during the 4th quarter. BNP Paribas Financial Markets now owns 210,317 shares of the company's stock valued at $34,158,000 after acquiring an additional 35,570 shares in the last quarter. 78.53% of the stock is owned by hedge funds and other institutional investors.

Clorox Stock Up 2.0%

NYSE CLX traded up $2.45 during mid-day trading on Friday, reaching $127.08. The stock had a trading volume of 3,231,696 shares, compared to its average volume of 1,756,627. The Clorox Company has a 1 year low of $116.53 and a 1 year high of $171.37. The stock has a market cap of $15.54 billion, a PE ratio of 19.49, a price-to-earnings-growth ratio of 1.02 and a beta of 0.52. The company has a fifty day moving average price of $124.17 and a 200 day moving average price of $133.35. The company has a debt-to-equity ratio of 5.15, a current ratio of 0.84 and a quick ratio of 0.57.

Clorox (NYSE:CLX - Get Free Report) last announced its quarterly earnings data on Thursday, July 31st. The company reported $2.87 earnings per share for the quarter, topping analysts' consensus estimates of $2.24 by $0.63. Clorox had a net margin of 11.40% and a return on equity of 377.86%. The company had revenue of $1.99 billion during the quarter, compared to analyst estimates of $1.94 billion. During the same period in the previous year, the business earned $1.82 EPS. The firm's revenue for the quarter was up 4.5% on a year-over-year basis. Clorox has set its FY 2026 guidance at 5.950-6.30 EPS. On average, research analysts expect that The Clorox Company will post 7.15 earnings per share for the current year.

Clorox Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, August 29th. Shareholders of record on Wednesday, August 13th were given a $1.24 dividend. This is a boost from Clorox's previous quarterly dividend of $1.22. The ex-dividend date of this dividend was Wednesday, August 13th. This represents a $4.96 dividend on an annualized basis and a yield of 3.9%. Clorox's payout ratio is presently 76.07%.

Analyst Ratings Changes

Several research firms have weighed in on CLX. Citigroup reaffirmed a "neutral" rating and set a $135.00 price objective (down from $140.00) on shares of Clorox in a research report on Tuesday, July 15th. Wells Fargo & Company lowered their target price on shares of Clorox from $138.00 to $130.00 and set an "equal weight" rating for the company in a report on Friday. JPMorgan Chase & Co. lowered their target price on shares of Clorox from $144.00 to $140.00 and set a "neutral" rating for the company in a report on Friday, July 25th. Barclays lowered their target price on shares of Clorox from $129.00 to $119.00 and set an "underweight" rating for the company in a report on Tuesday, July 15th. Finally, Morgan Stanley lowered their target price on shares of Clorox from $150.00 to $137.00 and set an "equal weight" rating for the company in a report on Friday, August 1st. One research analyst has rated the stock with a Buy rating, eight have assigned a Hold rating and two have given a Sell rating to the company's stock. According to data from MarketBeat, Clorox presently has an average rating of "Reduce" and a consensus price target of $142.64.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.